Massive study tests which palliative care model helps patients most
NCT ID NCT07224594
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two approaches to palliative care for seriously ill patients with a high risk of dying within a year. Over 78,000 patients across 48 hospitals will be assigned to usual care, care led by their own doctors (generalist), or care from a specialist team. Researchers will measure how many days patients spend out of the hospital and their quality of life to find out which model works best.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Palliative care delivery models (generalist vs. specialist)
- What this could lead to
- If successful, this could show which approach to palliative care works best for seriously ill patients, helping hospitals improve care and reduce suffering.
- What could go wrong
- This is a large pragmatic trial, but results depend on how well hospitals follow the assigned model. Differences between groups may be small, and patient-reported outcomes can be hard to collect from very ill participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 78,302 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
Jul 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 years of age or older; AND Predicted 1-year mortality risk of 70% or greater; AND Admitted to a study hospital. Exclusion Criteria: * Patients who die or have an active or completed discharge order prior to enrollment time OR * Readmission within 182 days of an eligible encounter OR * Ineligible service line, with current admission status labeled as: hospice, acute rehabilitation, skilled nursing facility, long-term acute care, psychiatry, obstetrics
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Seriously ill hospitalized patients are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Kaiser Permanente Southern California
Pasadena, California, 91101, United States
-
Trinity Health
Livonia, Michigan, 48152, United States